(Q42476456)

1 November 2017

BRCA1 and BRCA2 families and the risk of skin cancer (English)

1 reference

1 November 2017

William David Foulkes

3

1 reference

1 November 2017

7

Steven A Narod

1 reference

1 November 2017

Ophira M Ginsburg

1

1 reference

1 November 2017

Charmaine Kim-Sing

2

1 reference

1 November 2017

Parviz Ghadirian

4

1 reference

1 November 2017

Henry T Lynch

5

1 reference

1 November 2017

Ping Sun

6

1 reference

1 November 2017

Hereditary Breast Cancer Clinical Study Group

8

1 reference

1 November 2017

1 December 2010

1 reference

1 November 2017

1 reference

1 November 2017

9

1 reference

1 November 2017

4

1 reference

1 November 2017

489-493

1 reference

https://scigraph.springernature.com/pub.10.1007/s10689-010-9377-y

1 November 2017

0 references

cites work

Cancer Incidence in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9377-Y

On the use of familial aggregation in population-based case probands for calculating penetrance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9377-Y

Re: On the use of familial aggregation in population-based case probands for calculating penetrance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9377-Y

Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9377-Y

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9377-Y

BRCA2 mutation in Icelandic prostate cancer patients

21 January 2018

1 reference

12 December 2020

Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing

1 reference

12 December 2020

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

1 reference

12 December 2020

Re: On the use of familial aggregation in population-based case probands for calculating penetrance

1 reference

12 December 2020

BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers

1 reference

12 December 2020

Breast cancer risks for BRCA1/2 carriers

1 reference

12 December 2020

Different Expressivity of BRCA1 and BRCA2: Analysis of 179 Italian Pedigrees with Identified Mutation

1 reference

12 December 2020

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

1 reference

12 December 2020

BRCA2 germline mutations in familial pancreatic carcinoma

1 reference

12 December 2020

BRCA mutation frequency and penetrance: new data, old debate

1 reference

12 December 2020

Cancer risks in BRCA2 mutation carriers

1 reference

12 December 2020

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients

1 reference

12 December 2020

Frequency of BRCA1 and BRCA2 Mutations in Unselected Ashkenazi Jewish Patients With Colorectal Cancer

1 reference

12 December 2020

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

12 December 2020

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

1 reference

12 December 2020

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

1 reference

12 December 2020

BRCA2 mutations in a population-based series of patients with ocular melanoma

1 reference

12 December 2020

Re: On the use of familial aggregation in population-based case probands for calculating penetrance

1 reference

12 December 2020

BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer

1 reference

12 December 2020

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer

1 reference

12 December 2020

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

1 reference

12 December 2020

Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients

1 reference

12 December 2020

BRCA mutations and risk of prostate cancer in Ashkenazi Jews

1 reference

12 December 2020

A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals

1 reference

12 December 2020

Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations

1 reference

12 December 2020

BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma

1 reference

12 December 2020

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

1 reference

12 December 2020

Cancer risks among BRCA1 and BRCA2 mutation carriers

1 reference

12 December 2020

Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin.

1 reference

12 December 2020

Breast cancer risks for BRCA1/2 carriers

1 reference

12 December 2020

Re: On the use of familial aggregation in population-based case probands for calculating penetrance

1 reference

12 December 2020

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

12 December 2020

Nonmelanoma skin cancer in the United States: incidence.

1 reference

12 December 2020

Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status

1 reference

12 December 2020

Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands

1 reference

12 December 2020

Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers

1 reference

12 December 2020

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

1 reference

12 December 2020

Re: On the use of familial aggregation in population-based case probands for calculating penetrance

1 reference

12 December 2020

Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.

1 reference

12 December 2020

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

12 December 2020

10.1007/S10689-010-9377-Y

Identifiers

DOI

1 reference

release_lpqssy5qgvetpebmbamawllaku

1 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lpqssy5qgvetpebmbamawllaku

24 November 2022

mapped directly with Wikidata item

1 reference